Home › Calculator › BCTX Dividend Calculator 2026
BCTX Dividend DRIP Calculator 2026
57.31% YieldHealthcareBriaCell Therapeutics Corp. · NASDAQ
Price: $3.49 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BCTX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your BCTX snowball 📈
$10,000 in BCTX → $927.8K in 10 years · $28,167.32/month
About BriaCell Therapeutics Corp. (BCTX) — Dividend Analysis 2026
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer. Beyond its flagship program, BriaCell has forged a collaborative research and development partnership with the National Cancer Institute (NCI). This alliance is dedicated to progressing Bria-OTS, a personalized immunotherapy designed for advanced breast cancer patients, and BriaDx, a proprietary diagnostic assay. The company's main offices are situated in West Vancouver, Canada.
Compare BCTX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BCTX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BCTX position with:
🌍 BCTX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BCTX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 57.31% | 54.51% | $5,731 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 48.71% | 45.91% | $4,871 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 45.85% | 43.05% | $4,585 / yr |
| 🇬🇧 UK ISA | 0% | 57.31% | 54.51% | $5,731 / yr |
| 🇬🇧 UK Taxable | 8.75% | 52.30% | 49.50% | $5,230 / yr |
| 🇨🇦 TFSA | 0% | 57.31% | 54.51% | $5,731 / yr |
| 🇨🇦 CA Taxable | 25% | 42.98% | 40.18% | $4,298 / yr |
| 🇦🇺 Super (pension) | 15% | 48.71% | 45.91% | $4,871 / yr |
| 🇦🇺 AU Taxable | 30% | 40.12% | 37.32% | $4,012 / yr |
| 🇩🇪 DE Taxable | 26.375% | 42.19% | 39.39% | $4,219 / yr |
| 🇫🇷 FR Taxable | 30% | 40.12% | 37.32% | $4,012 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BCTX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BCTX Dividend Payment Schedule
BCTX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 BCTX vs Healthcare Benchmarks
How BCTX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BCTX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BCTX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2024-05-14 | 902,935 | $2.21 | $2.00M | ||
| Buy | 2024-05-14 | 902,935 | $2.11 | $1.91M | ||
| Buy | 2022-12-28 | 28,000 | $4.58 | $128.2K | ||
| Buy | 2022-12-23 | 2,530 | $1.94 | $4.9K | ||
| Buy | 2022-12-20 | 22,000 | $5.35 | $117.7K | ||
| Other | 2022-08-01 | 250,000 | $8.47 | $2.12M | ||
| Other | 2021-08-12 | 70,000 | $5.31 | $371.7K | ||
| Other | 2021-03-29 | 150,000 | $4.24 | $636.0K | ||
| Other | 2022-02-07 | 20,000 | $5.31 | $106.2K | ||
| Other | 2022-08-01 | 150,000 | $7.51 | $1.13M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BCTX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
BriaCell Therapeutics Corp. (BCTX) is currently trading at $3.49, 100% below its 52-week high. The current dividend yield is 57.31% based on an annual payout of $2.00 per share.
BCTX (BriaCell Therapeutics Corp.) — 57.31% Dividend Yield Analysis
BriaCell Therapeutics Corp. (BCTX) is a healthcare stock currently trading at $3.49 with a dividend yield of 57.31%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (57.31%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.